tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

GHRS Stock Latest News

GH Research price target lowered to $39 from $50 at JMP Securities
The FlyGH Research price target lowered to $39 from $50 at JMP Securities
2M ago
GHRS
GH Research Reports Full Year 2023 Financial Results and Provides Business Updates
PremiumPress Releases
GH Research Reports Full Year 2023 Financial Results and Provides Business Updates
2M ago
GHRS
GH Research reports FY23 EPS (68c), consensus (67c)
PremiumThe Fly
GH Research reports FY23 EPS (68c), consensus (67c)
2M ago
GHRS
GH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant Depression
PremiumPress Releases
GH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant Depression
3M ago
GHRS
EPO grants GH Research patent with claims directed to 5-MeO-DMT for MDD/TRD
PremiumThe Fly
EPO grants GH Research patent with claims directed to 5-MeO-DMT for MDD/TRD
3M ago
GHRS
GH Research price target lowered to $30 from $35 at Canaccord
PremiumThe FlyGH Research price target lowered to $30 from $35 at Canaccord
5M ago
GHRS
GH Research price target lowered to $40 from $45 at H.C. Wainwright
PremiumThe Fly
GH Research price target lowered to $40 from $45 at H.C. Wainwright
5M ago
GHRS
GH Research reports Q3 EPS (11c), consensus (20c)
PremiumThe Fly
GH Research reports Q3 EPS (11c), consensus (20c)
5M ago
GHRS
GH Research Reports Third Quarter Financial Results and Provides Business Updates
PremiumPress Releases
GH Research Reports Third Quarter Financial Results and Provides Business Updates
5M ago
GHRS
Eight new option listings on October 4th
PremiumThe Fly
Eight new option listings on October 4th
7M ago
CDL
CWS
GH Research Provides Updates and Guidance on its Clinical Development Program for GH001 in Treatment-Resistant Depression
PremiumPress Releases
GH Research Provides Updates and Guidance on its Clinical Development Program for GH001 in Treatment-Resistant Depression
7M ago
GHRS
GH Research Reports Second Quarter 2023 Financial Results and Provides Business Updates
PremiumPress Releases
GH Research Reports Second Quarter 2023 Financial Results and Provides Business Updates
8M ago
GHRS
GH Research reports Q2 EPS (15c), consensus (25c)
PremiumThe FlyGH Research reports Q2 EPS (15c), consensus (25c)
8M ago
GHRS
‘It’s Really a Brain Chemistry Issue’: Elon Musk Embraces Ketamine in the Battle Against Depression — Here Are 2 Psychedelic Stocks That Analysts Like
PremiumStock Analysis & Ideas
‘It’s Really a Brain Chemistry Issue’: Elon Musk Embraces Ketamine in the Battle Against Depression — Here Are 2 Psychedelic Stocks That Analysts Like
10M ago
CMPS
GHRS
GHRS Earnings this Week: How Will it Perform?
PremiumPre-Earnings
GHRS Earnings this Week: How Will it Perform?
11M ago
GHRS
GH Research Reports First Quarter 2023 Financial Results and Provides Business Highlights
PremiumPress Releases
GH Research Reports First Quarter 2023 Financial Results and Provides Business Highlights
11M ago
GHRS
Down More Than 50%: 2 ‘Strong Buy’ Stocks That Are Too Cheap to Ignore
PremiumStock Analysis & Ideas
Down More Than 50%: 2 ‘Strong Buy’ Stocks That Are Too Cheap to Ignore
1y ago
GHRS
ITOS
GH Research price target lowered to $35 from $41 at Canaccord
PremiumThe Fly
GH Research price target lowered to $35 from $41 at Canaccord
1y ago
GHRS
GH Research expects cash to fund requirements into 2026
PremiumThe Fly
GH Research expects cash to fund requirements into 2026
1y ago
GHRS
GH Research reports Q4 EPS (43.2c), consensus (17c)
PremiumThe FlyGH Research reports Q4 EPS (43.2c), consensus (17c)
1y ago
GHRS
GH Research Reports Full Year 2022 Financial Results and Provides Business Updates
PremiumPress Releases
GH Research Reports Full Year 2022 Financial Results and Provides Business Updates
1y ago
GHRS
GH Research provides business updates, key upcoming milestones
PremiumThe Fly
GH Research provides business updates, key upcoming milestones
1y ago
GHRS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >